维普期刊资源整合服务平台（V6.5）

48篇 您的检索式：作者名="Macconell"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type2diabetes(DURATION-2):a randomised trial显示文摘	Bergenstal RM Wysham C Macconell L	2010	Lancet2010，376，9739：	1
2	Effects of once-weekly dosing of a long-acting release formulation of exenatide on glucose control and body weight in subjects with type 2 diabetes显示文摘	KIM D MACCONELL L ZHUANG D	2007	Diabetes Care2007，30，6：	1
3	Effects of once-weekly dosing of a long-acting release formulation of exenatide on glucose control and body weight in subjects with type 2 diabetes显示文摘	Kim D MacConell L Zhuang D	2007	Diabetes Care2007，30，6：	1
4	Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2) : a randomised trial显示文摘	BERGENSTAL R M WYSHAM C MACCONELL L	2010	Lancet2010，376，9739：	1
5	Efficacy andsafety of exenatide once weekly versus sitagliptin or pioglitazoneas an adjunct to metformin for treatment of type 2 diabetes ( DU-RATION-2) :a randomised trial 显示文摘	Bergenstal RM Wysham C Macconell L	2010	Lancet2010，376，43：	1
6	Effects of once weekly dosing of a long-acting release formulation of exenatide on glucose control and body weight in subjects with type 2 diabetes显示文摘	Kim D Macconell L Zhuang D	2007	Diabetes Care2007，30，6：	1
7	Effect of once-weekly dosing of a long-acting release formulation of exenatide on glucose control and body weight in subjects with type 2 diabetes显示文摘	Kim D MacConell L Zhuang D	2007	Diabetes Care2007，30，6：	1
8	Effects of once-weekly dosing of a long-acting release formulation of exenatide on glucose control and body weight in subjects with type 2 diabetes显示文摘	Kim D MacConell L Zhuang D	2007	Diabetes Care2007，30，6：	1
9	Effi- cacy and safety of exenatide once weekly versus sitagliptin or pio-glitazone as an adjunct to metfomlin for treatment of type 2 diabe- tes (DURATION-2) : A randomised trial显示文摘	BERGENSTAL R M WYSHAM C MACCONELL L	2010	Lancet2010，376，9739：	1
10	Effects of once- weekly dosing of a long-acting release formulation of exenatide on glucose control and body weight in subjects with type 2 diabetes 显示文摘	KIM D MACCONELL L ZHUANG D	2007	Diabetes Care2007，30，6：	1
11	Comparison of safety and tol- erability with continuous ( exenatide once weekly ) or intermittent (exenatide twice daily)GLP-1 receptor agonism in patients with type 2 diabetes显示文摘	Ridge T Moretto T Macconell L	2012	Diabetes Obes Metab2012，14，12：	1
12	Effi- cacy and safety of exenatide once weekly versus sitagliptin or pio- glitazone as an adjunct to metformin for treatment of type 2 diabe- tes (DURATION-2) : A randomised trial显示文摘	BERGENSTAL RM WYSHAM C MACCONELL L	2010	Lancet2010，376，9739：	1
13	Safety and tolerability of exenatide twice daily in patients with type 2 diabetes: integrated analysis of 5594 patients from 19 placebo-controlled and comparator-controlled clinical trials 显示文摘	Macconell L Brown C Gurney K	2012	Diabetes Metab Syndr Obes2012，5，：	1
14	Safety and tolerability of exenatide twice daily in patients with type 2 diabetes:integrated analysis of 5594 patients from 19 placebo-controlled and comparator-controlled clinical trials显示文摘	Macconell L Brown C Gurney K	2012	Diabetes Metab Syndr Obes2012，5，：	1
15	Safety and tolerability of exenatide twice daily in patients with type 2 diabetes: integrated analysis of 5594 patients from 19 placebo-controlled and comparator-controlled clinical trials显示文摘	Kate Gurney Jenny Han Carl Brown Leigh MacConell	2012	Diabetes Metabolic Syndrome and Obesity: Targets and Therapy (default)2012，，：	1
16	Efficacy andsafety of exenatide once weekly versus sitagliptin or pioglitazone asan adjunct to metformin for treatment of type 2 diabetes(DURA-TION-2):a randomised trial显示文摘	Bergenstal RM Wysham C Macconell L	2010	Lancet2010，376，9739：	1
17	Efficacy and safe- ty of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes ( DURATION- 2) : a randomised trial显示文摘	Bergenstal RM Wysham C Macconell L	2010	Lancet2010，376，9739：	1
18	Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2) : a randomised trial显示文摘	Bergenstal RM Wysham C Macconell L	2010	Lancet2010，376，9739：	1
19	Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to mefformin for treatment of type 2 diabetes (DURATION-2): a randomised trial显示文摘	Bergenstal RM Wysham C Macconell L	2010	Lancet2010，376，9739：	1
20	Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type2diabetes(DURATION-2):a randomised trial显示文摘	Bergenstal RM Wysham C Macconell L	2010	Lancet2010，376，9739：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示